Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Veterinary Clinical Pathology
|
January 1, 1993
Aplastic anemia associated with prolonged high-dose trimethoprim-sulfadiazine administration in two dogs
Leslie E. Fox, Susan Ford, Arthur R. Alleman, et al.
Journal of Endourology
|
June 5, 2021
Outcomes in Patients with Known Contrast Allergy Undergoing Contrast-Enhanced Endourologic Procedures: A Retrospective Cohort Study
Jason P Joseph, Paula Domino, Vincent G Bird, et al.
Pharmaceutics
|
April 26, 2025
Matrix Approach Assessment of Cabotegravir Drug-Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling
Helen Tracey, Simon T Bate, Susan Ford, et al.
Pediatrics
|
March 9, 2018
Ohio Perinatal Quality Collaborative Improves Care of Neonatal Narcotic Abstinence Syndrome
Michele C Walsh, Moira Crowley, Scott Wexelblatt, et al.
Pediatric Quality & Safety
|
September 3, 2021
Quality Improvement Initiative to Improve Healthcare Providers' Attitudes towards Mothers with Opioid Use Disorder
Susan Ford, Leslie Clarke, Michele C Walsh, et al.
Pediatrics
|
September 11, 2020
Orchestrated Testing of Formula Type to Reduce Length of Stay in Neonatal Abstinence Syndrome
Heather C Kaplan, Pierce Kuhnell, Michele C Walsh, et al.
British Journal of Clinical Pharmacology
|
August 11, 2022
A population pharmacokinetic model based on HPTN 077 of long-acting injectable cabotegravir for HIV PrEP
Yifan Yu, Kristin L Bigos, Mark A Marzinke, et al.
American Journal of Perinatology
|
March 23, 2017
Using a State Birth Registry as a Quality Improvement Tool
Carole Lannon, Heather C Kaplan, Kelly Friar, et al.
The Journal of Antimicrobial Chemotherapy
|
May 4, 2020
Evaluation of the effect of UGT1A1 polymorphisms on the pharmacokinetics of oral and long-acting injectable cabotegravir
Parul Patel, Zhengyu Xue, Karen S King, et al.
The Journal of Antimicrobial Chemotherapy
|
December 25, 2019
Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults
Scott L Letendre, Anthony Mills, Debbie Hagins, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Veterinary Clinical Pathology
|
January 1, 1993
Aplastic anemia associated with prolonged high-dose trimethoprim-sulfadiazine administration in two dogs
Leslie E. Fox, Susan Ford, Arthur R. Alleman, et al.
Journal of Endourology
|
June 5, 2021
Outcomes in Patients with Known Contrast Allergy Undergoing Contrast-Enhanced Endourologic Procedures: A Retrospective Cohort Study
Jason P Joseph, Paula Domino, Vincent G Bird, et al.
Pharmaceutics
|
April 26, 2025
Matrix Approach Assessment of Cabotegravir Drug-Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling
Helen Tracey, Simon T Bate, Susan Ford, et al.
Pediatrics
|
March 9, 2018
Ohio Perinatal Quality Collaborative Improves Care of Neonatal Narcotic Abstinence Syndrome
Michele C Walsh, Moira Crowley, Scott Wexelblatt, et al.
Pediatric Quality & Safety
|
September 3, 2021
Quality Improvement Initiative to Improve Healthcare Providers' Attitudes towards Mothers with Opioid Use Disorder
Susan Ford, Leslie Clarke, Michele C Walsh, et al.
Pediatrics
|
September 11, 2020
Orchestrated Testing of Formula Type to Reduce Length of Stay in Neonatal Abstinence Syndrome
Heather C Kaplan, Pierce Kuhnell, Michele C Walsh, et al.
British Journal of Clinical Pharmacology
|
August 11, 2022
A population pharmacokinetic model based on HPTN 077 of long-acting injectable cabotegravir for HIV PrEP
Yifan Yu, Kristin L Bigos, Mark A Marzinke, et al.
American Journal of Perinatology
|
March 23, 2017
Using a State Birth Registry as a Quality Improvement Tool
Carole Lannon, Heather C Kaplan, Kelly Friar, et al.
The Journal of Antimicrobial Chemotherapy
|
May 4, 2020
Evaluation of the effect of UGT1A1 polymorphisms on the pharmacokinetics of oral and long-acting injectable cabotegravir
Parul Patel, Zhengyu Xue, Karen S King, et al.
The Journal of Antimicrobial Chemotherapy
|
December 25, 2019
Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults
Scott L Letendre, Anthony Mills, Debbie Hagins, et al.
Page
of 3